Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Case Report: Concomitant Lupus with Features of Scleroderma, Castleman Disease

Kwabna Parker, MBBS, Sireesha Datla, MD, & Nancy Soloman, MD  |  Issue: July 2016  |  July 11, 2016

Seven months later, she was readmitted for cellulitis of the right arm and found to have a neck mass and a new systolic murmur, and was noted to have pitted scars on her fingertips; at that point, she fulfilled the 2013 ACR/EULAR classification criteria for systemic sclerosis. A CT of her neck revealed persistent lymphadenopathy, and a 2D echo showed persistently elevated pulmonary arterial pressure of 44 mmHg.

Discussion

We present the case of a patient with newly diagnosed SLE and MCD and who also has evidence of EBV reactivation and features of systemic sclerosis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Castleman disease is a heterogeneous group of disorders with three histological types (i.e., hyaline vascular, plasma cell and mixed) and two clinical subtypes (i.e., localized and multicentric).1 Most cases of MCD occur in middle-aged men, and there is an association between MCD and HIV and human herpes virus 8.2,3 SLE, however, occurs mainly in women of childbearing age. The most common lymph node lesions in SLE are follicular hyperplasia and coagulative necrosis, with the latter being more specific.4

In one review of 33 SLE patients, lymph node pathology consistent with Castleman disease was found in 10% of these patients.4 The reported cases of concomitant MCD and SLE were mainly young to middle-aged women who were HIV negative, like our patient.5-10 Our patient was also noted to have evidence of EBV infection with IgM and IgG antibodies, as well as EBV DNA detected on PCR. These findings suggest that either her EBV infection was subacute or she was reinfected with EBV.11

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

EBV occurs worldwide, with over 80% of individuals older than 30 being infected. The infection persists for life and is associated with the development of malignancies, such as Burkitt’s lymphoma, Hodgkin’s disease and lymphoproliferative disorders.12 EBV has been reported in association with Castleman disease in variable frequencies, ranging from 2 out of 20 to 19 out of 20 cases.13,14 In one instance, EBV was reported to occur in MCD, with fatal results.15

IL-6 may be produced in an autocrine fashion from EBV-transformed B cells.16 Excessive IL-6 production in mice produces a syndrome characterized by anemia, transient granulocytosis, splenomegaly, hypoalbuminemia and polyclonal hypergammaglobulinemia, which closely resembles the systemic features of Castleman disease.17 The level of IL-6 produced by hyperplastic lymph nodes in patients with Castleman disease is directly related to the severity of clinical features and worsening of the lab results, which resolved with the removal of the lymph nodes.18

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsSystemic Sclerosis Tagged with:Castleman's diseaseClinicalLupusoutcomepatient carerheumatologySclerodermaSLE

Related Articles
    A positron emission tomography (PET) scan shows a 3 cm, hypermetabolic mass adjacent to the stomach.

    Case Report: Elevated Inflammatory Markers & a Hypermetabolic Mass

    December 16, 2021

    Consulting rheumatologists often assess patients with atypical clinical presentations for the possibility of an underlying rheumatic disease. Inflammatory syndromes that are not clearly rheumatic in nature can be particularly challenging to diagnose. Here, we share the case of a young woman with a long-standing undiagnosed illness and highly elevated inflammatory markers, and describe the evaluation…

    Regressed germinal center with follicular dendritic cell prominence (star), onion-skinning (blue arrowhead) and increased vascularity (orange arrows) are seen.

    Case Report: Is It Castleman Disease, or Castleman-Like?

    October 13, 2021

    The difference between Castle­man disease and Castleman-like disease may be subtle, but it comes with significant ramifications. Case Presentation This case involves a pregnant 19-year-old woman who presents over multiple hospitalizations with concerns for systemic lupus erythematosus and macrophage activation syndrome. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAt 36 weeks’ gestation, the patient’s weight had dropped from…

    Search for Infectious Triggers of Rheumatic Disease Could Yield Options to Block Process

    January 19, 2016

    SAN FRANCISCO—Two hundred years ago, physicians knew nothing about what caused various forms of arthritis. Today, we have more clues about what may trigger rheumatic diseases, but still can’t pinpoint the culprits that set scores of inflammatory conditions in motion. Researchers discussed some of the background and recent findings that point to what immunologists call…

    What’s the Role of Epstein-Barr Virus Reactivation in Lupus Development?

    November 12, 2020

    A strong association between Epstein-Barr virus (EBV) infections and systemic lupus erythematosus (SLE) has been known since the 1970s. Although the etiology of SLE is not fully established, multiple genetic factors and polymorphisms in genes involved in the immune system have been implicated, with environmental factors also contributing to the development of this complex condition….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences